Hydroxyurea CAS NO.127-07-1
- FOB Price: USD: 70.00-100.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
99%(1-5)Kilogram99%(5-10)Kilogram
- Product Details
Keywords
- 127-07-1
- Animal Pharmaceuticals
- antitumor
Quick Details
- ProName: Hydroxyurea
- CasNo: 127-07-1
- Molecular Formula: CH4N2O2
- Appearance: White Powder
- Application: antitumor
- DeliveryTime: Shipped in 15 days after payment
- PackAge: according to customers' requirements
- Port: China main port
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: 2 years
- Transportation: International express delivery
- LimitNum: 1 Kilogram
Superiority
About us
Our company has been in existence for 10 years since its establishment. We have our own unique team. The company integrates independent research and development, production and sales. We have established famous brands at home and abroad. At present, our customers have spread all over the world, we have rich Transportation experience, we aim to serve customers, to help customers, solve problems for customers. Look forward to working with you!
Details
Product name
Hydroxyurea CAS:127-07-1
Packaging, Storage &Shelf Life
Package
1kg/bag,25kg/ drum
Storage
Stored in original packaging for two years at a temperature not exceeding 40°C.
Shelf life
2 years if sealed and stored properly.
Specification
Item |
Standard |
Test Results |
|
Identification |
A.H-NMR:Comply with the structure |
Complies |
|
B.LC-MS:Comply with the structure |
Complies |
||
C.The IR spectrum of sample should be identical with that of reference standard; |
Complies |
||
D.HPLC-ESI-MS The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay. |
Complies |
||
Crystallinity |
meets the requirements. |
Complies |
|
Loss on drying |
≤2.0% |
0.19% |
|
Heavy metals |
≤10 ppm |
<10ppm |
|
Water |
≤1.0% |
0.1% |
|
Sulphated ash |
≤0.5%, determined on 1.0 g. |
0.009% |
|
Related substances |
Unspecified impurities: for each impurity |
≤0.10% |
<0.10% |
Total Impurity |
≤0.5% |
0.18% |
|
Purity |
≥99.0% |
99.7% |
|
Assay |
99.0%~101.0% (anhydrous substance). |
99.8% |
|
Microbiological Analysis |
|||
Total plate count |
≤1000cfu/g |
Complies |
|
Yeast and Moulds |
≤100cfu/g |
Complies |
Applications
Hydroxyurea is a nucleoside diphosphate reductase inhibitor, can prevent nucleotide reduction for DNA, interfere with the purine and pyrimidine bases biosynthesis, selective blocking DNA synthesis, partially inhibit RNA into DNA nucleotides.
Hydroxyurea specific drugs for cycle, sensitive to S phase cells, can induce the hematology ease of chronic myelogenous leukemia, and alkylating agent white Ann elimination, horses, compared to flange secondary leukemia incidence is low.
this product is a derivative of 5-fluorouracil, the role and application of the product is the same as 5-fluorouracil, but it has less toxicity and its chemotherapy index is high. After the activion by the liver in vivo ,it becomes 5-fluorouracil to play a role in cancer. It is effective on Gastric cancer, colon cancer, colorectal cancer, pancreatic cancer and breast cancer, lung cancer. |